Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 491 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

BRIEF COMMUNICATION

Resistant prolactinoma: Is it monoclonal or polyclonal?

Kumar K. V. S. Hari, Prusty Pitambar

Year : 2013| Volume: 17| Issue : 7 | Page no: 139-141

   This article has been cited by
 
1 Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature
Elizabeth Ogando-Rivas,Andrew F. Alalade,Jerome Boatey,Theodore H. Schwartz
Pituitary. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Isolated double adrenocorticotropic hormone-secreting pituitary adenomas: A case report and review of the literature
JIUJUN PU,ZHIMING WANG,HUI ZHOU,AILING ZHONG,KAI JIN,LUNLIANG RUAN,GANG YANG
Oncology Letters. 2016; 12(1): 585
[Pubmed]  [Google Scholar] [DOI]
3 Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
Hua Gao,Fei Wang,Xiaolei Lan,Chuzhong Li,Jie Feng,Jiwei Bai,Lei Cao,Songbai Gui,Lichuan Hong,Yazhuo Zhang
BMC Cancer. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article